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Introduction
We present an interesting case where a patient developed 
secondary adrenal insufficiency following multiple intra-
articular steroid injections. 
Methods
A 59-year-old woman presented with fatigue and 50 
pounds weight gain in the last two years. She has been 
receiving triamcinolone steroid injections in both knees 
every three months for the last two years. She has also 
been receiving triamcinolone injections in ankles 
sporadically during this time period. Laboratory evaluation
showed undetectable serum cortisol and inappropriately 
normal serum adrenocorticotropic hormone (ACTH). The 
patient underwent cosyntropin stimulation test confirming
secondary adrenal insufficiency (Table 1). Magnetic 
resonance imaging (MRI) showed a normal pituitary gland 
with no tumors. She was started on hydrocortisone 10mg 
twice daily with improvement in fatigue. The patient was 
recommended to minimize steroid injections. The plan is 
to taper steroid subsequently. 
Table 1. Laboratory studies
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Secondary adrenal insufficiency (SAI) is the decrease in
adrenal glucocorticoid production due to dysfunction in
the hypothalamic- pituitary- adrenal (HPA) axis. The most 
common cause of SAI is exogenous glucocorticoid
administration, and is dependent on dosage, amount, and 
duration. SAI can be seen as early as three weeks after 
administration of high doses of corticosteroids and 
symptoms can occur within 48 hours of withdrawal.  The 
HPA axis can take up to 18 months or longer to recover. 
Clinicians are relatively familiar with the risk of secondary 
 adrenal insufficiency (SAI) with the use of high dose 
systemic glucocorticoids.  The occurrence of symptomatic
SAI following glucocorticoid joint injections is less well 
 known. Studies have shown systemic absorption of steroid
following a single joint injection leading to decreased 
serum cortisol production.2 The risk factors of axis 
suppression include multiple joints injection, split dosage, 
and higher doses of steroid. The reports of clinically 
significant AI secondary to intra-articular joint injections 
are rare, but there are case reports of emergent 
manifestations in both the pediatric and adult 
population.3,4 There are currently no well established 
guidelines for frequency of intraarticular joint injections.5 
Conclusion
This case highlights that intraarticular steroid injections do 
have systemic adverse effects and the need for more 
awareness among clinicians.  This case supports the need 
for further evaluation of the risks of SAI with the number 
of joint injections, the frequency of injections, and the 
time interval between multiple intraarticular steroid
injections. 
Figure 1. Hypothalamic pituitary axis1 
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